Abstract
Recent reports introduce a novel cell subset of DCs with antigenic phenotypes shared by both NK cells and B cells, but without surface markers of pDCs and T cells, appearing to be a chimera of NK cells and DCs, namely interferon-producing killer dendritic cells (IKDCs). IKDCs not only secret type I and type II interferons to recognize and kill tumor cells effectively, but also express MHC-II molecules to present antigens. Thus, IKDCs are considered as important immunosurveilance cells for tumors, providing a link between innate and adaptive immunity.
Similar content being viewed by others
References
Josien R, Heslan M, Soulillou J P, et al. Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR-P1) and have cytotoxic activity to select targets via a Ca2+-dependent mechanism. J Exp Med, 1997, 186(3): 467–472, 9236200, 10.1084/jem.186.3.467, 1:CAS:528:DyaK2sXlt1Snsb0%3D
Trinite B, Voisine C, Yagita H, et al. A subset of cytolytic dendritic cells in rat. J Immunol, 2000, 165(8): 4202–4208, 11035052, 1:CAS:528:DC%2BD3cXnslWgtb8%3D
Homann D, Jahreis A, Wolfe T, et al. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity, 2002, 16(3): 403–415, 11911825, 10.1016/S1074-7613(02)00290-X, 1:CAS:528:DC%2BD38Xis1Wmsbw%3D
Pillarisetty V G, Katz S C, Bleier J I, et al. Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-gamma via autocrine IL-12. J Immunol, 2005, 174(5): 2612–2618, 15728467, 1:CAS:528:DC%2BD2MXhsFeqsr4%3D
Chen L, Calomeni E, Wen J, et al. Natural killer dendritic cells are an intermediate of developing dendritic cells. J Leukoc Biol, 2007, 81(6): 1422–1433, 17332372, 10.1189/jlb.1106674, 1:CAS:528:DC%2BD2sXmt1Oks74%3D
Spits H, Lanier L L. Natural killer or dendritic: What’s in a name? Immunity, 2007, 26(1): 11–16, 17241957, 10.1016/j.immuni.2007.01.004, 1:CAS:528:DC%2BD2sXhsFKit7k%3D
Taieb J, Chaput N, Menard C, et al. A novel dendritic cell subset involved in tumor immunosurveillance. Nat Med, 2006, 12(2): 214–219, 16444265, 10.1038/nm1356, 1:CAS:528:DC%2BD28XhtFWqu7c%3D
Chan C W, Crafton E, Fan H N, et al. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat Med, 2006, 12(2): 207–213, 16444266, 10.1038/nm1352, 1:CAS:528:DC%2BD28XhtFWqu70%3D
Shortman K, Villadangos J A. Is it a DC, is it an NK? No, it’s an IKDC. Nat Med, 2006, 12(2): 167–168, 16462794, 10.1038/nm0206-167, 1:CAS:528:DC%2BD28XhtFWqt7s%3D
Young H A. Unraveling the pros and cons of interferon-gamma gene regulation. Immunity, 2006, 24(5): 506–507, 16713967, 10.1016/j.immuni.2006.05.004, 1:CAS:528:DC%2BD28XlsFWqsbo%3D
Hoshino K, Sugiyama T, Matsumoto M, et al. IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature, 2006, 440(7086): 949–953, 16612387, 10.1038/nature04641, 1:CAS:528:DC%2BD28XjsVWktbo%3D
Bogdan C, Schleicher U. Production of interferon-gamma by myeloid cells—Fact or fancy? Trends Immunol, 2006, 27(6): 282–290, 16698319, 10.1016/j.it.2006.04.004, 1:CAS:528:DC%2BD28Xls1aqtbw%3D
Vremec D, O’Keeffe M, Hochrein H, et al. Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells. Blood, 2007, 109(3): 1165–1173, 17038535, 10.1182/blood-2006-05-015354, 1:CAS:528:DC%2BD2sXjtFertL0%3D
Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: Immunoselection and immunosubversion. Nat Rev Immunol, 2006, 6(10): 715–727, 16977338, 10.1038/nri1936, 1:CAS:528:DC%2BD28XhtVSgurnM
Smyth M J, Swann J, Kelly J M, et al. NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer. J Exp Med, 2004, 200(10): 1325–1335, 15545356, 10.1084/jem.20041522, 1:CAS:528:DC%2BD2cXhtVSisrzM
Arnon T I, Markel G, Mandelboim O. Tumor and viral recognition by natural killer cells receptors. Semin Cancer Biol, 2006, 16(5): 348–358, 16893656, 10.1016/j.semcancer.2006.07.005, 1:CAS:528:DC%2BD28XpsVWktr4%3D
Smyth M J, Takeda K, Hayakawa Y, et al. Nature’s TRAIL—On a path to cancer immunotherapy. Immunity, 2003, 18(1): 1–6, 12530970, 10.1016/S1074-7613(02)00502-2, 1:CAS:528:DC%2BD3sXnvVykuw%3D%3D
Suss G, Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med, 1996, 183(4): 1789–1796, 8666935, 10.1084/jem.183.4.1789, 1:STN:280:BymB287mslw%3D
Fanger N A, Maliszewski C R, Schooley K, et al. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Exp Med, 1999, 190(8): 1155–1164, 10523613, 10.1084/jem.190.8.1155, 1:CAS:528:DyaK1MXmslKis7s%3D
Welner R S, Pelayo R, Garrett K P, et al. Interferon-producing killer dendritic cells (IKDCs) arise via a unique differentiation pathway from primitive c-kitHiCD62L+ lymphoid progenitors. Blood, 2007, 109(11): 4825–4831, 17317852, 10.1182/blood-2006-08-043810, 1:CAS:528:DC%2BD2sXmt1Ogurs%3D
Caminschi I, Ahmet F, Heger K, et al. Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells. J Exp Med, 2007, 204(11): 2579–2590, 17923506, 10.1084/jem.20071351, 1:CAS:528:DC%2BD2sXht1KnurjM
Blasius A L, Barchet W, Cella M, et al. Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells. J Exp Med, 2007, 204(11): 2561–2568, 17923504, 10.1084/jem.20070991, 1:CAS:528:DC%2BD2sXht1KnurvE
Vosshenrich C A, Lesjean-Pottier S, Hasan M, et al. CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells. J Exp Med, 2007, 204(11): 2569–2578, 17923507, 10.1084/jem.20071451, 1:CAS:528:DC%2BD2sXht1KnurvF
Robbins S H, Walzer T, Dembele D, et al. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol, 2008, 9(1): R17, 18218067, 10.1186/gb-2008-9-1-r17
Ullrich E, Bonmort M, Mignot G, et al. Therapy-induced tumor immunosurveillance involves IFN-producing killer dendritic cells. Cancer Res, 2007, 67(3): 851–853, 17283111, 10.1158/0008-5472.CAN-06-3766, 1:CAS:528:DC%2BD2sXht1ynt7Y%3D
Asavaroengchai W, Wang H, Wang S, et al. An essential role for IFN-gamma in regulation of alloreactive CD8 T cells following allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant, 2007, 13(1): 46–55, 17222752, 10.1016/j.bbmt.2006.09.014, 1:CAS:528:DC%2BD2sXitVelsrs%3D
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the National Natural Science Foundation of China (Grant No. 30471635), and Natural Science Foundation of Guangdong Province in China (Grant Nos. 04010451 and 5006033)